SCHEMBL4028009

SCHEMBL4028009

O=C(c1ccc2cc(OS(=O)(=O)C(F)(F)F)ccc2c1)c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.35
CNR2 P34972 1/20 0.35
HSD11B1 P28845 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA4 P22748 2/20 0.35
CA9 Q16790 2/20 0.35
DRD2 P14416 5/20 0.34
DRD3 P35462 5/20 0.34
SIRT2 Q8IXJ6 3/20 0.34
ENPP3 O14638 1/20 0.34
ENPP1 P22413 1/20 0.34
PPARD Q03181 3/20 0.33
PPARG P37231 2/20 0.32
PPARA Q07869 2/20 0.32
CHRM1 P11229 1/20 0.32
DRD4 P21917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5678341 0.85 KDM4E (0.46) CNR2SIRT2
SCHEMBL1414946 0.85 SIRT2 (0.34) PTPN1CNR2SIRT2PPARDPPARG
SCHEMBL5682251 0.83 LMNA (0.42) SIRT2PPARDPPARGPPARA
SCHEMBL5750032 0.82 ALOX5 (0.44)
SCHEMBL4030987 0.82 MEN1 (0.51) CNR2CA1CA2CA4CA9
SCHEMBL4024355 0.81 SIRT2 (0.41) SIRT2
SCHEMBL4024513 0.81 CA12 (0.38) CA1CA9SIRT2PPARDPPARG
SCHEMBL313125 0.79 ACSS2 (0.43) SIRT2
SCHEMBL312503 0.78 HPGD (0.42) CA1CA2CA4CA9SIRT2
SCHEMBL7539383 0.78 SIRT2 (0.33) PTPN1CNR2CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222174-B1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA PHARMACEUTICAL (JP) 2009-05-27 EP disclosed
US-6649643-B1 Antitumor, anticarcinogenic, and antimetastasis agents; benign prostatic hyperplasia, alopecia, endometriosis, uterine myoma, hirsutism, virilism, precocious puberty, mastopathy, and polycystic overay syndrome treatment TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-11-18 US disclosed
EP-1222174-A1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE Takeda Chemical Industries, Ltd. (JP) 2002-07-17 EP disclosed
WO-2001030762-A1 IMIDAZOL-4-YLMETHANOLS USE AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-03 WO disclosed